Results: 30
Molecular pathogenesis of myeloproliferative neoplasms: Where do we stand in 2023?
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1512, doi. 10.1002/ajh.27062
- By:
- Publication type:
- Article
Marginal zone lymphoma: 2023 update on diagnosis and management.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1645, doi. 10.1002/ajh.27058
- By:
- Publication type:
- Article
Sequencing‐based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1627, doi. 10.1002/ajh.27044
- By:
- Publication type:
- Article
Performance of IPSS‐M in patients with myelodysplastic syndrome after hypomethylating agent failure.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E281, doi. 10.1002/ajh.27043
- By:
- Publication type:
- Article
F‐erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1598, doi. 10.1002/ajh.27042
- By:
- Publication type:
- Article
Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph<sup>+</sup>ALL: A retrospective nationwide study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1606, doi. 10.1002/ajh.27041
- By:
- Publication type:
- Article
Updates in chronic graft‐versus‐host disease management.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1637, doi. 10.1002/ajh.27040
- By:
- Publication type:
- Article
Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real‐world retrospective multi‐institutional cohort.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E285, doi. 10.1002/ajh.27039
- By:
- Publication type:
- Article
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single‐arm, open‐label, phase 2, multicenter study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1588, doi. 10.1002/ajh.27033
- By:
- Publication type:
- Article
Long‐term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E288, doi. 10.1002/ajh.27038
- By:
- Publication type:
- Article
Jaktinib and momelotinib for the treatment of myelofibrosis—Birds of a feather?
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1517, doi. 10.1002/ajh.27036
- By:
- Publication type:
- Article
Peripheral blood evidence of iron overload.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1658, doi. 10.1002/ajh.27035
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitor therapy and unmasking of JAK2‐mutated myeloproliferative neoplasm: A Mayo Clinic series of nine consecutive cases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E276, doi. 10.1002/ajh.27034
- By:
- Publication type:
- Article
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single‐arm, open‐label, phase 2, multicenter study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1579, doi. 10.1002/ajh.27031
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1619, doi. 10.1002/ajh.27037
- By:
- Publication type:
- Article
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1559, doi. 10.1002/ajh.27030
- By:
- Publication type:
- Article
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
- By:
- Publication type:
- Article
Low risk of relapse in aplastic anemia patients after SARS‐CoV‐2 omicron infection: A prospective NICHE cohort.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E272, doi. 10.1002/ajh.27028
- By:
- Publication type:
- Article
Return visits after emergency department treatment for sickle cell pain crises.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E266, doi. 10.1002/ajh.27027
- By:
- Publication type:
- Article
Bortezomib and daratumumab in refractory autoimmune hemolytic anemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E263, doi. 10.1002/ajh.27025
- By:
- Publication type:
- Article
"Severity" in adult sickle cell disease.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1508, doi. 10.1002/ajh.27024
- By:
- Publication type:
- Article
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E269, doi. 10.1002/ajh.27022
- By:
- Publication type:
- Article
Increased transferrin protects from thrombosis in Chuvash erythrocytosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1532, doi. 10.1002/ajh.27021
- By:
- Publication type:
- Article
The MAGIC algorithm probability (MAP)‐guided preemptive therapy of acute graft versus host disease with methylprednisolone: A randomized controlled trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1550, doi. 10.1002/ajh.27020
- By:
- Publication type:
- Article
Autologous hematopoietic stem cell transplantation for a patient with multiple autoimmune diseases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1659, doi. 10.1002/ajh.27011
- By:
- Publication type:
- Article
Acute myeloid leukemia as an adverse event in a patient treated with a poly(ADP‐ribose) polymerase (PARP) inhibitor.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1665, doi. 10.1002/ajh.26969
- By:
- Publication type:
- Article
Peripheral blood cells vacuoles in VEXAS syndrome.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1663, doi. 10.1002/ajh.26931
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1505, doi. 10.1002/ajh.26613
- Publication type:
- Article
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1520, doi. 10.1002/ajh.27013
- By:
- Publication type:
- Article